Author: Rojas, Manuel; RodrÃguez, Yhojan; Zapata, Elizabeth; Hernández, Juan Carlos; Anaya, Juan-Manuel
Title: Cholangiopathy as part of post-COVID syndrome Cord-id: rp95no7u Document date: 2021_8_31
ID: rp95no7u
Snippet: Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this cond
Document: Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.
Search related documents:
Co phrase search for related documents- abdominal cardiac and liver disease: 1
Co phrase search for related documents, hyperlinks ordered by date